Loading... Please wait... Loading... Please wait...
| Reporting Date | Major Shareholder Name | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| 05/15/2024 | LYNX1 CAPITAL MANAGEMENT LP | 814,467 | $838,901 | -1.19% | 8.59% |
| 05/15/2024 | POINT72 ASSET MANAGEMENT, L.P. | 316,000 | $325,480 | -4.53% | 3.33% |
| 05/15/2024 | TWO SIGMA INVESTMENTS, LP | 17,070 | $17,582 | -45.41% | 0.18% |
| 05/01/2024 | LEWIS ASSET MANAGEMENT, LLC | 15,000 | $15,450 | 100.00% | 0.16% |
| 05/14/2024 | BEACON POINTE ADVISORS, LLC | 10,000 | $10,300 | 100.00% | 0.11% |
| 05/13/2024 | UBS GROUP AG | 9,933 | $10,231 | 2,919.15% | 0.10% |
| 05/09/2024 | RHUMBLINE ADVISERS | 1,305 | $1,343 | 158.42% | 0.01% |
| 04/18/2024 | ASPIRE PRIVATE CAPITAL, LLC | 200 | $206 | 0.00% | 0.00% |
| 05/15/2024 | MORGAN STANLEY | 94 | $97 | -99.90% | 0.00% |
| 05/10/2024 | JPMORGAN CHASE & CO | 1 | $1 | 100.00% | 0.00% |
| 05/15/2024 | TOWER RESEARCH CAPITAL LLC (TRC) | 0 | $0 | -100.00% | 0.00% |
| 05/13/2024 | XTX TOPCO LTD | 0 | $0 | -100.00% | 0.00% |
A. During the previous two years, 14 institutional investors and hedge funds held shares of Bionomics Limited. The most heavily invested institutionals were:
Lynx1 Capital Management LP: 814,467
Point72 Asset Management, L.P.: 316,000
TWO SIGMA INVESTMENTS, LP: 17,070
Lewis Asset Management, LLC: 15,000
Beacon Pointe Advisors, LLC: 10,000
UBS Group AG: 9,933
A. 12.48% of Bionomics Limited stock is owned by institutional investors.
A. Institutional investors have bought a total of 1.34 M shares in the last 24 months. This purchase volume represents approximately $936,833 in transactions.
